Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

SELL
$5.66 - $7.59 $112,237 - $150,509
-19,830 Reduced 22.89%
66,799 $431,000
Q1 2023

May 12, 2023

BUY
$7.31 - $11.18 $507,438 - $776,082
69,417 Added 403.31%
86,629 $653,000
Q4 2022

Feb 13, 2023

SELL
$9.48 - $14.52 $656,471 - $1.01 Million
-69,248 Reduced 80.09%
17,212 $174,000
Q3 2022

Nov 07, 2022

BUY
$9.2 - $13.68 $196,429 - $292,081
21,351 Added 32.79%
86,460 $855,000
Q2 2022

Aug 09, 2022

BUY
$5.72 - $10.65 $372,423 - $693,410
65,109 New
65,109 $693,000
Q2 2021

Aug 12, 2021

SELL
$20.19 - $34.17 $8,782 - $14,863
-435 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$23.29 - $53.2 $10,131 - $23,142
435 New
435 $14,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.